Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23354105 | 0.98 | ADAMTS7 (0.33) | ADAMTS7ADAM17 | |
| Hydrochloric Acid SCHEMBL29979629 | 0.98 | ADAMTS7 (0.33) | ADAMTS7ADAM17 | |
| Hydrochloric Acid SCHEMBL29980219 | 0.82 | ADAMTS7 (0.32) | ADAMTS7 | |
| SCHEMBL23371329 | 0.82 | ADAMTS7 (0.44) | ADAMTS7ADAM17 | |
| Hydrochloric Acid SCHEMBL23354184 | 0.81 | ADAMTS7 (0.43) | ADAMTS7ADAM17 | |
| Hydrochloric Acid SCHEMBL31676887 | 0.81 | ADAMTS7 (0.43) | ADAMTS7ADAM17 | |
| SCHEMBL23354019 | 0.79 | ADAMTS7 (0.43) | ADAMTS7ADAM17 | |
| SCHEMBL31676866 | 0.76 | ADAM17 (0.35) | ADAMTS7ADAM17 | |
| SCHEMBL23361634 | 0.76 | ADAM17 (0.35) | ADAMTS7ADAM17 | |
| Hydrochloric Acid SCHEMBL23353990 | 0.75 | ADAM17 (0.34) | ADAMTS7ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAM17 | ADAMTS7 1/4885ADAM17 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.